Search clinical trials for: Patritumab and Trastuzumab
Total 273274 results
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Hospital Universitario Madrid SanchinarroUnknown
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Daiichi SankyoRecruitingAdvanced Solid TumorJapan, United States
-
Shanghai JMT-Bio Inc.Not yet recruitingFirst-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
-
Cancer Insight, LLCGenentech, Inc.; Sellas Life Sciences GroupCompleted
-
CinnagenCompletedHER2-positive Breast CancerIran, Islamic Republic of
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownHER2-positive Metastatic Breast CancerChina
-
Baylor Breast Care CenterGlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Bulgaria, Spain, Poland, Finland, United Kingdom, Austria, Italy, Greece, Czech Republic, Croatia
-
University of Alabama at BirminghamJohns Hopkins University; Georgetown University; University of Chicago; University... and other collaboratorsActive, not recruitingMetastatic Breast Cancer | Leptomeningeal DiseaseUnited States
-
Reva BashoMerck Sharp & Dohme LLC; Seagen Inc.WithdrawnBreast Cancer | HER2-positive Breast Cancer | Brain Metastases | CNS DiseaseUnited States
-
CelltrionUnknownMetastatic Breast CancerKorea, Republic of
-
Hoffmann-La RocheCompletedBreast CancerKazakhstan, Belarus
-
Merrimack PharmaceuticalsTerminatedStomach Cancer | Gastroesophageal Junction Cancer | HER-2 Gene Amplification | Esophagus CancerUnited States
-
Hoffmann-La RocheCompleted
-
Translational Oncology Research InternationalGenentech, Inc.Completed
-
Amsterdam UMC, location VUmcUnknownNSCLC | EGFR-mutation | HER2-expressionNetherlands
-
Seagen Inc.RecruitingGastric Adenocarcinoma | Cholangiocarcinoma | Esophageal Adenocarcinoma | Colorectal Carcinoma | Gallbladder Carcinoma | GEJ AdenocarcinomaUnited States, Japan
-
Memorial Sloan Kettering Cancer CenterSanofi; University of Pittsburgh; Medical College of Wisconsin; Weill Medical College... and other collaboratorsCompletedGastric Cancer | Gastroesophageal Junction AdenocarcinomaUnited States
-
Nanfang Hospital, Southern Medical UniversityRecruiting
-
The First Affiliated Hospital with Nanjing Medical...Anhui Provincial Cancer Hospital; Affiliated Hospital of Jiangnan University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School and other collaboratorsRecruiting
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingHER2-positive Breast CancerChina
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast Cancer | Carcinoma of the BreastUnited States
-
CelltrionUnknownMetastatic Breast CancerRomania
-
Incyte CorporationTerminated
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingEsophageal Cancer | Esophageal AdenocarcinomaNetherlands
-
Washington University School of MedicineThe Foundation for Barnes-Jewish Hospital; Curis, Inc.RecruitingStomach Cancer | Gastric Cancer | Esophageal Cancer | Gastroesophageal Junction Cancer | Esophagus CancerUnited States
-
Hoffmann-La RocheActive, not recruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaChina
-
Universidade Federal do ParaCompleted
-
Universidade Federal do ParaCompletedDentin SensitivityBrazil
-
Zhejiang Cancer HospitalUnknownBreast Cancer | Breast Diseases | Neoplasm, BreastChina
-
Michelle MeliskoTerminatedPhase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+Solid TumorUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedCancer | Advanced Solid Tumors | TumorsUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingSolid Tumor | Haematological MalignancyUnited Kingdom
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
National Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerUnited States, Japan
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute, NaplesWithdrawn
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
Oslo University HospitalVestre Viken Hospital Trust; University Hospital of North Norway; Ostfold Hospital... and other collaboratorsRecruitingCancer MetastaticNorway
-
Zhejiang Hisun Pharmaceutical Co. Ltd.Completed
-
Ludwig-Maximilians - University of MunichPierre Fabre LaboratoriesCompletedCarcinoma Breast Stage IVGermany
-
Dana-Farber Cancer InstituteSusan G. Komen Breast Cancer Foundation; Breast Cancer Research Foundation; Terri...Active, not recruiting
-
Genentech, Inc.Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Canada, China, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Spain, United Kingdom, Brazil, Guatemala, Japan, Russian Federation, Singapore, Thailand, Latvia, Argentina, Poland, Ecuador, Mexico, Croatia and more
-
BiocadCompletedHuman Epithelial Receptor (HER)-2 Positive Breast CancerUkraine, Russian Federation, Belarus, India
-
Hoffmann-La RocheCompletedBreast CancerSweden, Canada, South Africa, Spain, United Kingdom, Germany, Taiwan, Switzerland, New Zealand, Italy, Bosnia and Herzegovina, Serbia, Portugal, Greece, Romania, Brazil, Korea, Republic of, Mexico, Croatia, Bahamas